PanCareSurPass Project HL7 FHIR Implementation Guide
0.1.0 - trial-use 150

This page is part of the PanCareSurPass Project HL7 FHIR Implementation Guide (v0.1.0: QA Preview) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Logical Model: TreatmentSummary - Detailed Descriptions

Active as of 2023-01-26

Definitions for the TreatmentSummary logical model.

Guidance on how to interpret the contents of this table can be found here.

1. TreatmentSummary
Definition

Treatment Summary data model Maturity Level: 2 - Ready for Review

Control0..?
2. TreatmentSummary.subject
Definition

Subject

Control1..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Subject
3. TreatmentSummary.diagnosis
Definition

Diagnosis

Control0..5
TypeBackboneElement
4. TreatmentSummary.diagnosis.details
Definition

Details about this diagnosis

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Diagnosis
5. TreatmentSummary.diagnosis.frontLineTreatment
Definition

Front line treatment

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/FrontLineTreatment
6. TreatmentSummary.diagnosis.chemotherapy
Definition

Chemotherapy

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Chemotherapy
7. TreatmentSummary.diagnosis.stemCellTransplantation
Definition

Stem Cell transplantation

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/StemCellTransplantation
8. TreatmentSummary.diagnosis.radiotherapy
Definition

Radiotherapy

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Radiotherapy
9. TreatmentSummary.diagnosis.majorSurgery
Definition

Major Surgery

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/MajorSurgery
10. TreatmentSummary.diagnosis.otherInfos
Definition

Other info and relevant events

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/OtherInfos
11. TreatmentSummary.diagnosis.medicalSuggestion
Definition

Medical suggestion

Control0..1
Typestring
12. TreatmentSummary.diagnosis.relapseDuringFLT
Definition

Progression-Relapse during Front line treatment

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/RelapseDuringFLT
13. TreatmentSummary.diagnosis.relapseAfterEOT
Definition

Progression-relapse after the End of Treatment

Control0..*
TypeBackboneElement
14. TreatmentSummary.diagnosis.relapseAfterEOT.details
Definition

Details about this relapse-progression

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/RelapseAfterFLT
15. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment
Definition

The salvage treatment has been executed following

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/FrontLineTreatment
16. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse
Definition

Details not provided for relapses after EOT

Control0..0
TypeBackboneElement
17. TreatmentSummary.diagnosis.relapseAfterEOT.chemotherapy
Definition

Chemotherapy

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Chemotherapy
18. TreatmentSummary.diagnosis.relapseAfterEOT.stemCellTransplantation
Definition

Stem Cell transplantation

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/StemCellTransplantation
19. TreatmentSummary.diagnosis.relapseAfterEOT.radiotherapy
Definition

Radiotherapy

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Radiotherapy
20. TreatmentSummary.diagnosis.relapseAfterEOT.majorSurgery
Definition

Major Surgery

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/MajorSurgery
21. TreatmentSummary.diagnosis.relapseAfterEOT.otherInfos
Definition

Other info and relevant events

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/OtherInfos
22. TreatmentSummary.diagnosis.relapseAfterEOT.medicalSuggestion
Definition

Medical suggestion

Control0..1
Typestring
23. TreatmentSummary.diagnosis.otherConditions
Definition

Please list here if the patient has or had other medical conditions not reported to be cancer-associated (e.g. diabetes, congenital cardiopathy, amputations, kidney transplant)

Control0..*
Typestring

Guidance on how to interpret the contents of this table can be found here.

1. TreatmentSummary
Definition

Treatment Summary data model Maturity Level: 2 - Ready for Review

Control0..*
2. TreatmentSummary.subject
Definition

Subject

Control1..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Subject
3. TreatmentSummary.diagnosis
Definition

Diagnosis

Control0..5
TypeBackboneElement
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
4. TreatmentSummary.diagnosis.modifierExtension
Definition

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Control0..*
TypeExtension
Is Modifiertrue
Summarytrue
Requirements

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Alternate Namesextensions, user content, modifiers
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
5. TreatmentSummary.diagnosis.details
Definition

Details about this diagnosis

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Diagnosis
6. TreatmentSummary.diagnosis.frontLineTreatment
Definition

Front line treatment

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/FrontLineTreatment
7. TreatmentSummary.diagnosis.chemotherapy
Definition

Chemotherapy

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Chemotherapy
8. TreatmentSummary.diagnosis.stemCellTransplantation
Definition

Stem Cell transplantation

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/StemCellTransplantation
9. TreatmentSummary.diagnosis.radiotherapy
Definition

Radiotherapy

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Radiotherapy
10. TreatmentSummary.diagnosis.majorSurgery
Definition

Major Surgery

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/MajorSurgery
11. TreatmentSummary.diagnosis.otherInfos
Definition

Other info and relevant events

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/OtherInfos
12. TreatmentSummary.diagnosis.medicalSuggestion
Definition

Medical suggestion

Control0..1
Typestring
13. TreatmentSummary.diagnosis.relapseDuringFLT
Definition

Progression-Relapse during Front line treatment

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/RelapseDuringFLT
14. TreatmentSummary.diagnosis.relapseAfterEOT
Definition

Progression-relapse after the End of Treatment

Control0..*
TypeBackboneElement
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
15. TreatmentSummary.diagnosis.relapseAfterEOT.modifierExtension
Definition

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Control0..*
TypeExtension
Is Modifiertrue
Summarytrue
Requirements

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Alternate Namesextensions, user content, modifiers
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
16. TreatmentSummary.diagnosis.relapseAfterEOT.details
Definition

Details about this relapse-progression

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/RelapseAfterFLT
17. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment
Definition

The salvage treatment has been executed following

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/FrontLineTreatment
18. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse
Definition

Details not provided for relapses after EOT

Control0..1
TypeBackboneElement
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
19. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse.modifierExtension
Definition

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Control0..*
TypeExtension
Is Modifiertrue
Summarytrue
Requirements

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Alternate Namesextensions, user content, modifiers
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
20. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse
Definition

Details not provided for relapses after EOT

Control0..0
TypeBackboneElement
21. TreatmentSummary.diagnosis.relapseAfterEOT.chemotherapy
Definition

Chemotherapy

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Chemotherapy
22. TreatmentSummary.diagnosis.relapseAfterEOT.stemCellTransplantation
Definition

Stem Cell transplantation

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/StemCellTransplantation
23. TreatmentSummary.diagnosis.relapseAfterEOT.radiotherapy
Definition

Radiotherapy

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Radiotherapy
24. TreatmentSummary.diagnosis.relapseAfterEOT.majorSurgery
Definition

Major Surgery

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/MajorSurgery
25. TreatmentSummary.diagnosis.relapseAfterEOT.otherInfos
Definition

Other info and relevant events

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/OtherInfos
26. TreatmentSummary.diagnosis.relapseAfterEOT.medicalSuggestion
Definition

Medical suggestion

Control0..1
Typestring
27. TreatmentSummary.diagnosis.otherConditions
Definition

Please list here if the patient has or had other medical conditions not reported to be cancer-associated (e.g. diabetes, congenital cardiopathy, amputations, kidney transplant)

Control0..*
Typestring

Guidance on how to interpret the contents of this table can be found here.

1. TreatmentSummary
Definition

Treatment Summary data model Maturity Level: 2 - Ready for Review

Control0..*
2. TreatmentSummary.subject
Definition

Subject

Control1..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Subject
3. TreatmentSummary.diagnosis
Definition

Diagnosis

Control0..5
TypeBackboneElement
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
4. TreatmentSummary.diagnosis.id
Definition

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

Control0..1
Typestring
XML RepresentationIn the XML format, this property is represented as an attribute.
Summaryfalse
5. TreatmentSummary.diagnosis.extension
Definition

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

Control0..*
TypeExtension
Summaryfalse
Alternate Namesextensions, user content
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
SlicingThis element introduces a set of slices on TreatmentSummary.diagnosis.extension. The slices are unordered and Open, and can be differentiated using the following discriminators:
  • value @ url
6. TreatmentSummary.diagnosis.modifierExtension
Definition

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Control0..*
TypeExtension
Is Modifiertrue
Summarytrue
Requirements

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Alternate Namesextensions, user content, modifiers
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
7. TreatmentSummary.diagnosis.details
Definition

Details about this diagnosis

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Diagnosis
8. TreatmentSummary.diagnosis.frontLineTreatment
Definition

Front line treatment

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/FrontLineTreatment
9. TreatmentSummary.diagnosis.chemotherapy
Definition

Chemotherapy

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Chemotherapy
10. TreatmentSummary.diagnosis.stemCellTransplantation
Definition

Stem Cell transplantation

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/StemCellTransplantation
11. TreatmentSummary.diagnosis.radiotherapy
Definition

Radiotherapy

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Radiotherapy
12. TreatmentSummary.diagnosis.majorSurgery
Definition

Major Surgery

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/MajorSurgery
13. TreatmentSummary.diagnosis.otherInfos
Definition

Other info and relevant events

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/OtherInfos
14. TreatmentSummary.diagnosis.medicalSuggestion
Definition

Medical suggestion

Control0..1
Typestring
15. TreatmentSummary.diagnosis.relapseDuringFLT
Definition

Progression-Relapse during Front line treatment

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/RelapseDuringFLT
16. TreatmentSummary.diagnosis.relapseAfterEOT
Definition

Progression-relapse after the End of Treatment

Control0..*
TypeBackboneElement
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
17. TreatmentSummary.diagnosis.relapseAfterEOT.id
Definition

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

Control0..1
Typestring
XML RepresentationIn the XML format, this property is represented as an attribute.
Summaryfalse
18. TreatmentSummary.diagnosis.relapseAfterEOT.extension
Definition

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

Control0..*
TypeExtension
Summaryfalse
Alternate Namesextensions, user content
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
SlicingThis element introduces a set of slices on TreatmentSummary.diagnosis.relapseAfterEOT.extension. The slices are unordered and Open, and can be differentiated using the following discriminators:
  • value @ url
19. TreatmentSummary.diagnosis.relapseAfterEOT.modifierExtension
Definition

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Control0..*
TypeExtension
Is Modifiertrue
Summarytrue
Requirements

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Alternate Namesextensions, user content, modifiers
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
20. TreatmentSummary.diagnosis.relapseAfterEOT.details
Definition

Details about this relapse-progression

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/RelapseAfterFLT
21. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment
Definition

The salvage treatment has been executed following

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/FrontLineTreatment
22. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.followedProtocol
Definition

Followed Protocol

Control0..*
TypeBackboneElement
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
23. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.followedProtocol.id
Definition

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

Control0..1
Typestring
XML RepresentationIn the XML format, this property is represented as an attribute.
Summaryfalse
24. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.followedProtocol.extension
Definition

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

Control0..*
TypeExtension
Summaryfalse
Alternate Namesextensions, user content
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
SlicingThis element introduces a set of slices on TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.followedProtocol.extension. The slices are unordered and Open, and can be differentiated using the following discriminators:
  • value @ url
25. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.followedProtocol.modifierExtension
Definition

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Control0..*
TypeExtension
Is Modifiertrue
Summarytrue
Requirements

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Alternate Namesextensions, user content, modifiers
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
26. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.followedProtocol.type
Definition

2 => Trial/protocol 2 => Personalized 3 => Guidelines -9922 => NK

Control0..1
TypeCodeableConcept
27. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.followedProtocol.name
Definition

Protocole name

Control0..1
Typestring
28. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.followedProtocol.description
Definition

If a specific trial/protocol was used, please specify.
In case of relapse/progression during front line treatment,please report both the name of the front line as well of the salvage treatment If personalized, please specify.

Control0..1
Typestring
29. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.followedProtocol.arm
Definition

If the trial was randomized, please define randomization arm

Control0..1
Typestring
30. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.dateEOT
Definition

It might be the date of first elective end of treatment, or that of the second (or further) end of treatment after the first one. If the date is unkown or partially missed insert the year at the best of your knowledge.

Control0..1
TypedateTime
31. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.isChemotherapy
Definition

Chemotherapy ?

Control0..1
TypeCodeableConcept
32. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.isStemCellTransplantation
Definition

Stem Cell transplantation ?

Control0..1
TypeCodeableConcept
33. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.isRadiotherapy
Definition

Radiotherapy ?

Control0..1
TypeCodeableConcept
34. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.isMajorSurgery
Definition

Major Surgery ?

Control0..1
TypeCodeableConcept
35. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse
Definition

Details not provided for relapses after EOT

Control0..1
TypeBackboneElement
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
36. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse.id
Definition

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

Control0..1
Typestring
XML RepresentationIn the XML format, this property is represented as an attribute.
Summaryfalse
37. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse.extension
Definition

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

Control0..*
TypeExtension
Summaryfalse
Alternate Namesextensions, user content
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
SlicingThis element introduces a set of slices on TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse.extension. The slices are unordered and Open, and can be differentiated using the following discriminators:
  • value @ url
38. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse.modifierExtension
Definition

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Control0..*
TypeExtension
Is Modifiertrue
Summarytrue
Requirements

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Alternate Namesextensions, user content, modifiers
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
39. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse.completeRemission
Definition

Complete remission

Control0..1
TypeBackboneElement
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
40. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse.completeRemission.id
Definition

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

Control0..1
Typestring
XML RepresentationIn the XML format, this property is represented as an attribute.
Summaryfalse
41. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse.completeRemission.extension
Definition

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

Control0..*
TypeExtension
Summaryfalse
Alternate Namesextensions, user content
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
SlicingThis element introduces a set of slices on TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse.completeRemission.extension. The slices are unordered and Open, and can be differentiated using the following discriminators:
  • value @ url
42. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse.completeRemission.modifierExtension
Definition

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Control0..*
TypeExtension
Is Modifiertrue
Summarytrue
Requirements

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Alternate Namesextensions, user content, modifiers
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
43. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse.completeRemission.status
Definition

Complete remission (Yes/No)

Control1..1
TypedateTime
44. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse.completeRemission.description
Definition

Textual description in case of no remission

Control1..1
TypeCodeableConcept
45. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse.isProgressionRelapseDuringFLT
Definition

Progression/relapse during frontline treatment ?

Control0..1
TypeCodeableConcept
46. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse.isProgressionRelapseAfterFLT
Definition

Progression/relapse after first elective end of treatment ?

Control0..1
TypeCodeableConcept
47. TreatmentSummary.diagnosis.relapseAfterEOT.frontLineTreatment.notForRelapse
Definition

Details not provided for relapses after EOT

Control0..0
TypeBackboneElement
48. TreatmentSummary.diagnosis.relapseAfterEOT.chemotherapy
Definition

Chemotherapy

Control0..1
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Chemotherapy
49. TreatmentSummary.diagnosis.relapseAfterEOT.stemCellTransplantation
Definition

Stem Cell transplantation

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/StemCellTransplantation
50. TreatmentSummary.diagnosis.relapseAfterEOT.radiotherapy
Definition

Radiotherapy

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/Radiotherapy
51. TreatmentSummary.diagnosis.relapseAfterEOT.majorSurgery
Definition

Major Surgery

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/MajorSurgery
52. TreatmentSummary.diagnosis.relapseAfterEOT.otherInfos
Definition

Other info and relevant events

Control0..*
Typehttp://hl7.eu/fhir/ig/pcsp/StructureDefinition/OtherInfos
53. TreatmentSummary.diagnosis.relapseAfterEOT.medicalSuggestion
Definition

Medical suggestion

Control0..1
Typestring
54. TreatmentSummary.diagnosis.otherConditions
Definition

Please list here if the patient has or had other medical conditions not reported to be cancer-associated (e.g. diabetes, congenital cardiopathy, amputations, kidney transplant)

Control0..*
Typestring